Candel Therapeutics

OverviewSuggest Edit

Candel Therapeutics (also known as Advantagene) is a biopharmaceutical company developing cancer immunotherapies. It develops Gene Mediated Cytotoxic Immunotherapy (GMCI), a platform technology designed to stimulate a patient’s immune system to naturally fight against cancer.

TypePrivate
HQArlington, VA, US
Websitecandeltx.com

Locations

Candel Therapeutics is headquartered in
Arlington, United States

Location Map

Latest Updates

Employees (est.) (Jan 2021)39(+26%)
Cybersecurity ratingAMore

Candel Therapeutics Office Locations

Candel Therapeutics has offices in Arlington and Needham
Arlington, VA, US (HQ)
Rosslyn
Needham, MA, US
117 Kendrick St #450
Show all (2)

Candel Therapeutics Financials and Metrics

Summary Metrics

Candel Therapeutics total Funding

$51.2 m

Candel Therapeutics latest funding size

$22.50 m

Time since last funding

2 years ago

Candel Therapeutics investors

Candel Therapeutics's latest funding round in April 2019 was reported to be $22.5 m. In total, Candel Therapeutics has raised $51.2 m
Show all financial metrics

Candel Therapeutics Cybersecurity Score

Cybersecurity ratingPremium dataset

A

95/100

SecurityScorecard logo

Candel Therapeutics Online and Social Media Presence

Embed Graph

Candel Therapeutics Frequently Asked Questions

  • How many employees does Candel Therapeutics have?

    Candel Therapeutics has 39 employees.

  • Who are Candel Therapeutics competitors?

    Competitors of Candel Therapeutics include OncoResponse, Northwest Biotherapeutics and Moleculin Biotech.

  • Where is Candel Therapeutics headquarters?

    Candel Therapeutics headquarters is located at Rosslyn, Arlington.

  • Where are Candel Therapeutics offices?

    Candel Therapeutics has offices in Arlington and Needham.

  • How many offices does Candel Therapeutics have?

    Candel Therapeutics has 2 offices.